OSTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OS Therapies Inc (OSTX) is not a strong buy for a beginner, long-term investor at this time. The stock lacks clear positive catalysts, has bearish technical indicators, insider selling, and weak financial performance. While the stock has a slight pre-market gain, the lack of strong proprietary trading signals and concerning fundamentals suggest holding off on investment for now.
The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 60.197, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 1.408), suggesting limited upside in the short term.
The MACD is slightly positive, indicating mild bullish momentum. The stock has a 60% chance of gaining 1.59% in the next day and 4.71% in the next week.
and declining EPS (-2.50% YoY). Analysts have lowered the price target to $14 from $17, citing dilution concerns.
In Q4 2025, the company reported no revenue growth (0% YoY), a significant net loss of -$13,460,833 (though improved by 171.21% YoY), and a declining EPS of -0.39 (-2.50% YoY). Gross margin remains at 0%.
Lake Street maintains a Buy rating but has lowered the price target from $17 to $14 due to recent dilution and capital activity.
